Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_24_библиотеки_им_акад_М_И_Перельмана
.pdf
194
https://t.me/medicina_free
T. Hirano and S.-y. Kawaguchi
Purkinje cells during development and show motor discoordination (Jacobson 1991). Purkinje cell-specic vesicular
GABA transporter knockout mice are defective in GABA
release and show motor discoordination without apparent
morphological abnormality (Kayakabe et al. 2014). A
transgenic mouse line in which Golgi cells can be ablated at
a desired timing was constructed (Watanabe etal. 1998).
Golgi cell ablation in this mouse model induces severe
motor discoordination followed by partial recovery, which
is accompanied with suppressed NMDA receptor-mediated
synaptic response in granule cells. This suppression of
excitatory response in a granule cell seems to counteract
the loss of GABAergic inhibition caused by Golgi cell
ablation, potentially contributing to the partial recovery of
motor coordination.
Transgenic mouse lines in which GABAergic synaptic
transmission onto Purkinje cells are depressed have also
been generated. In one type, GABAA receptor γ2 subunit was
knocked out (Wulff et al. 2009a). The mice show drastic
reduction in GABAergic synaptic response in a Purkinje cell
and motor learning defects. However, the mice show apparently normal motor coordination. A previous study reported
that acute suppression of GABAergic synaptic transmission
by drug application causes severe motor discoordination
(Wulff et al. 2009b). Therefore, a relatively mild effect of
chronic suppression of GABAergic transmission might be
ascribed to some compensatory mechanisms in the
cerebellum.
29.5 GABA inCerebellar Ataxia
As mice models with defects in GABAergic neurons or synapses show motor discoordination and/or motor learning
failures, some dysfunction in the cerebellar GABAergic systems might be a cause of cerebellar ataxia in human patients.
Indeed, some patients have autoantibody against glutamate
decarboxylase (GAD), an enzyme catalyzing production of
GABA from glutamate (Vianello etal. 2003). The antibody
suppresses GABA release from basket cells depressing
inhibitory synaptic transmission to Purkinje cells. The autoantibodies against GAD65, one of the two types of GAD,
collected from patients of cerebella ataxia were shown to be
internalized into cytoplasm, and indeed pathogenic when
applied to rodents (Mitoma etal. 2017). An agrypnia patient
showing ataxia has autoantibody against GABAB receptor,
which might affect GABA systems in the cerebellum
(Frisullo etal. 2007).
In a mouse model of episodic ataxia type 1, mutation of a
type of K+ channel increases the frequency and amplitude of
spontaneous GABAergic postsynaptic currents in a Purkinje
cell, which might be a cause of episodic ataxia (Herson etal.
2003). On the other hand, GABA-mimetic drug gabapentin
improves motor coordination in some spinocerebellar ataxia
type six patients (Nakamura etal. 2009), suggesting that the
drug treatment to modulate GABA system is therapeutically
effective in some ataxic patients.
References
Barmack NH, Yakhnitsa V (2008) Functions of interneurons in mouse
cerebellum. J Physiol 28:1140–1152
Brickley SG, Revilla V, Cull-Candy SG, Wisden W, Farrant M
(2001) Adaptive regulation of neuronal excitability by a voltageindependent potassium conductance. Nature 409:88–92
Brown AM, Arancillo M, Lin T, Catt DR, Zhou J, Lackey EP, Stay TL,
Zuo Z, White JJ, Sillitoe RV (2019) Molecular layer interneurons
shape the spike activity of cerebellar Purkinje cells. Sci Rep 9:1742.
https://doi.org/10.1038/s41598- 018- 38264- 1
Chalifoux JR, Carter AG (2011) GABAB receptor modulation of synap-
tic function. Curr Opin Neurobiol 21:339–344
de San Martin JZ, Trigo FF, Kawaguchi SY (2017) Axonal GABAA
receptors depolarize presynaptic terminals and facilitate transmitter
release in cerebellar Purkinje cells. J Physiol 595:7477–7493
Dean P, Porrill J, Ekerot CF, Jorntell H (2010) The cerebellar microcir-
cuit as an adaptive lter: experimental and computational evidence.
Nat Rev Neurosci 11:30–43
Dittman JS, Regehr WG (1996) Contributions of calcium-dependent
and calcium-independent mechanisms to presynaptic inhibition at a
cerebellar synapse. J Neurosci 16:1623–1633
Dugue GP, Brunel N, Hakim V, Schwartz E, Chat M, Levesque M,
Courtemanche R, Lena C, Dieudonne S (2009) Electrical coupling
mediates tunable low-frequency oscillations and resonance in the
cerebellar Golgi cell network. Neuron 61:126–139
Duguid IC, Smart TG (2004) Retrograde activation of presynaptic
NMDA receptors enhances GABA release at cerebellar interneuronPurkinje cell synapses. Nat Neurosci 7:525–533
Frisullo G, Marca GD, Mirabella M, Caggiula M, Broccolini A, Rubino
M, Mennuni G, Tonali PA, Batocchi AP (2007) A human antineuronal autoantibody against GABAB receptor induces experimental autoimmune agrypnia. Exp Neurol 204:808–818
Hausser M, Clark BA (1997) Tonic synaptic inhibition modulates
neuronal output pattern and spatiotemporal synaptic integration.
Neuron 19:665–678
Herson PS, Virk M, Rustay N, Bond CT, Crabbe JC, Adelman JP,
Maylie J (2003) A mouse model of episodic ataxia type-1. Nat
Neurosci 6:378–383
Hirano T (2013) Long-term depression and other synaptic plasticity in
the cerebellum. Proc Jpn Acad Ser B Phys Biol Sci 89:183–195
Hirano T (2021) GABA and synaptic transmission in the cerebellum.
In: Manto M, Gruol DL, Schmahmann JD, Koibuchi N, Sillitoe R
(eds) Handbook of the cerebellum and cerebellar disorders, 2nd
edn. Springer, NewYork
Hirano T, Kawaguchi S (2014) Regulation and functional roles of
rebound potentiation at cerebellar stellate cell—Purkinje cell
synapses. Front Cell Neurosci 8:42. https://doi.org/10.3389/
fncel.2014.000421- 8
Ito M (2001) Cerebellar long-term depression: characterization, signal
transduction, and functional roles. Physiol Rev 81:1143–1195
Ito M (2006) Cerebellar circuitry as a neuronal machine. Prog Neurobiol
78:272–303
Jacobson M (1991) Developmental neurobiology. Plenum Press,
NewYork
Kano M, Rexhausen U, Dreessen J, Konnerth A (1992) Synaptic exci-
tation produces a long-lasting rebound potentiation of inhibitory
synaptic signals in cerebellar Purkinje cells. Nature 356:601–604

29 GABA Pathways andReceptors
https://t.me/medicina_free
195
Kayakabe M, Kakizaki T, Kaneko R, Sasaki A, Nakazato Y, Shibasaki
K, Ishizaki Y, Saito H, Suzuki N, Furuya N, Yanagawa Y (2014)
Motor dysfunction in cerebellar Purkinje cell-specic vesicular
GABA transporter knockout mice. Front Cell Neurosci 7:286.
https://doi.org/10.3389/fncel.2013.00286
Kim J, Augustine GJ (2021) Molecular layer interneurons: key elements
of cerebellar network computation and behavior. Neuroscience
462:22–35
Lee S, Yoon B, Berglund K, Oh S, Park H, Shin H, Augustine GJ,
Lee CJ (2010) Channel-mediated tonic GABA release from glia.
Science 330:790–796
Lujan R, Shigemoto R (2006) Localization of metabotropic GABA
receptor subunits GABAB1 and GABAB2 relative to synaptic sites in
the rat developing cerebellum. Eur J Neurosci 23:1479–1490
Ma M, Futia GL, de Souza FMS, Ozbay BN, Llano I, Gibson EA,
Restrepo D (2020) Molecular layer interneurons in the cerebel-
lum encode for valence in associative learning. Nat Commun
11:4217
Mann-Metzer P, Yarom Y (1999) Electrotonic coupling interacts with
intrinsic properties to generate synchronized activity in cerebellar
networks of inhibitory interneurons. J Neurosci 19:3298–3306
Mitoma H, Manto M, Hampe CS (2017) Pathogenic roles
of glutamic acid decarboxylase 65 autoantibodies in cer-
ebellar ataxias. J Immunol Res 2017:2913297. https://doi.
org/10.1155/2017/2913297
Nakamura K, Yoshida K, Miyazaki D, Morita H, Ikeda S (2009)
Spinocerebellar ataxia type 6 (SCA6): clinical pilot trial with gaba-
pentin. J Neurol Sci 278:107–111
Olsen RW, Sieghart W (2009) GABAA receptors: subtypes provide
diversity of function and pharmacology. Neuropharmacology
56:141–148
Rowan MJM, Bonnan A, Zhang K, Amat SB, Kikuchi C, Taniguchi H,
Augustine GJ, Christie JM (2018) Graded control of climbing-ber-
mediated plasticity and learning by inhibition in the cerebellum.
Neuron 99:999–1015
Saxena NC, Macdonald RL (1996) Properties of putative cerebel-
lar γ-aminobutyric acid A receptor isoforms. Mol Pharmacol
49:567–579
Tanaka S, Kawaguchi S, Shioi G, Hirano T (2013) Long-term poten-
tiation of inhibitory synaptic transmission onto cerebellar Purkinje
neurons contributes to adaptation of vestibulo-ocular reex. J
Neurosci 33:17209–17220
Vianello M, Tavolato B, Armani M, Giometto B (2003) Cerebellar
ataxia associated with anti-glutamic acid decarboxylase autoantibodies. Cerebellum 2:77–79
Watanabe D, Inokawa H, Hashimoto K, Suzuki N, Kano M, Shigemoto
R, Hirano T, Toyama K, Kaneko S, Yokoi M, Moriyoshi K, Suzuki
M, Kobayashi K, Nagatsu T, Kreitman RJ, Pastan I, Nakanishi S
(1998) Ablation of cerebellar Golgi cells disrupts synaptic integration involving GABA inhibition and NMDA receptor activation in
motor coordination. Cell 95:17–28
Wisden W, Korpi ER, Bahn S (1996) The cerebellum: a model sys-
tem for studying GABAA receptor diversity. Neuropharmacology
35:1139–1160
Wulff P, Goetz T, Leppa E, Linden A, Renzi M, Swinney JD,
Vekovischeva OY, Sighart W, Somogyi P, Korpi ER, Farrant M,
Wisden W (2009a) From synapse to behavior: rapid modulation
of dened neuronal types with engineered GABAA receptors. Nat
Neurosci 10:923–929
Wulff P, Schonewille M, Renzi M, Viltono L, Sassoè-Pognetto M,
Badura A, Gao Z, Hoebeek F, van Dorp S, Wisden W, Farrant M,
De Zeeuw C (2009b) Synaptic inhibition of Purkinje cells mediates
consolidation of vestibulo-cerebellar motor learning. Nat Neurosci
12:1042–1049
Yoshida T, Hashimoto K, Zimmer A, Maejima T, Araishi K, Kano M
(2002) The cannabinoid CB1 receptor mediates retrograde signals
for depolarization-induced suppression of inhibition in cerebellar
Purkinje cells. J Neurosci 22:1690–1697
Zeng N, Raman IM (2010) Synaptic inhibition, excitation, and plastic-
ity in neurons of the cerebellar nuclei. Cerebellum 9:56–66

Glutamatergic Pathways andReceptors
https://t.me/medicina_free
SusumuTomita
30
Abstract
Glutamate is a major excitatory neurotransmitter in the
vertebrate brain and is utilized at distinct synapses in the
cerebellum. Glutamate released from presynaptic termi-
nals binds to various types and classes of glutamate recep-
tors at pre- and post-synapses. Glutamate receptors are
classied as metabotropic (mGluR) or ionotropic (iGluR).
iGluRs function as glutamate-gated cation channels and
are classied pharmacologically as AMPA-, NMDA-, or
kainite-types. AMPA receptors determine synaptic
strength, whereas NMDA receptors induce synaptic plas-
ticity. Kainate receptors play multiple roles in regulating
synaptic transmission and plasticity. mGluRs are G
protein- coupled receptors that modulate postsynaptic sig-
naling by the type I mGluRs through Gq signaling and
modulate glutamate release via the type II and III mGluRs
acting via Gi/o signaling. Combinatory action among the
glutamate receptors coordinates synaptic transmission
and synaptic plasticity. Disruption of receptor activities
causes various neurological disorders including epilepsy,
mental retardation, and neurodegenerative diseases, and
controlling glutamate receptor activities is used as a thera-
peutic strategy for these disorders. This chapter covers
topics of glutamate receptors and their auxiliary
subunits.
Keywords
30.1 Glutamatergic Pathways andSynaptic
Transmission
Neurons communicate with each other at synapses through
the release and uptake of neurotransmitters. One major excitatory neurotransmitter in the vertebrate brain is glutamate. In
the cerebellum, glutamate is used as a neurotransmitter at
various synapses such as mossy ber to granule cells, parallel ber to Golgi cells, parallel ber to stellate cells, parallel
ber to Basket cells, parallel ber to Purkinje cells, and
climbing ber to Purkinje cells (Ito 2006; Jakab and Hamori
1988). Synaptic transmission is initiated when glutamate is
released from the presynaptic terminals upon depolarization
of the terminals by the arrival of an action potential.
Subsequently, glutamate binds to and activates glutamate
receptors at pre- and postsynaptic membranes. At each synapse, unique classes of glutamate receptors are expressed
and localized to mediate characteristic synaptic properties.
30.2 Glutamate Receptors
The various subtypes of metabotropic and ionotropic glutamate receptors are illustrated in Fig. 30.1 (Hollmann and
Heinemann 1994; Nakanishi 1992; Wisden and Seeburg
1993).
Glutamate receptor · Synapse · Metabotropic glutamate
receptor · AMPA receptor · Kainate receptor · NMDA
receptor
S. Tomita (*)
Department of Cellular and Molecular Physiology, Yale University
School of Medicine, New Haven, CT, USA
Department of Neuroscience, Yale University School of Medicine,
New Haven, CT, USA
e-mail: Susumu.Tomita@yale.edu
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023
D. L. Gruol et al. (eds.), Essentials of Cerebellum and Cerebellar Disorders, https://doi.org/10.1007/978-3-031-15070-8_30
30.2.1 Metabotropic Glutamate Receptors
(mGluRs)
mGluRs are classic G protein-coupled receptors (GPCRs)
that contain a conserved seven transmembrane domain and
play major roles in modulating intracellular second messenger signaling. Upon glutamate binding, type I (1/5) mGluR
activates protein kinase C (PKC) and inositol triphosphate
(IP3) signaling through Gq-mediated phospholipase C (PLC)
activation. Subsequently, the phosphorylation of PKC sub-
197

198
https://t.me/medicina_free
S. Tom it a
Fig. 30.1 Glutamate receptor complex. Glutamate receptors are classied as metabotropic and ionotropic receptors. mGluRs mediates various G protein signaling dependent on mGluR isoforms. Each ionotropic
receptor is a heterotetramer with distinct auxiliary subunits that modu-
strates or an increase in intracellular calcium (Ca2+) mediated
via IP3 receptors modulates postsynaptic functions. Type II
(2/3) and III (4/6/7/8) mGluRs couple with Gi/o to reduce
cAMP levels through Gi/o-mediated adenylate cyclase inhibition. In addition, type II/III mGluRs are primarily localized on presynaptic membranes where these receptors
modulate neurotransmitter release.
mGluRs are implicated in various neurological diseases,
including depression, schizophrenia, pain, epilepsy, and neurodegenerative diseases (Bear etal. 2004; Niswender and Conn
2010). The disruption of mGluR expression is associated with
multiple neurological diseases. For example, mGluR1 knockout mice show severe ataxia (Aiba etal. 1994). In addition, the
disruption of mGluR functions is observed in Fragile X mental
retardation, and mGluR5 knockout mice show mental retardation-like phenotypes (Bear et al. 2004; Dolen et al. 2007).
Therefore, mGluRs are recognized as a therapeutic target for
the treatment of various neurological disorders.
30.2.2 Ionotropic Glutamate Receptors
(iGluRs)
iGluRs are glutamate-gated cationic channels and are further
classied pharmacologically as AMPA-, NMDA-, and
kainate- sensitive glutamate receptors (Fig.30.1) (Hollmann
and Heinemann 1994; Nakanishi 1992; Wisden and Seeburg
late receptor properties and/or localization. AMPA receptor (AMPAR)
interacts with transmembrane AMPA receptor regulatory protein
(TARP) and kainate receptor (KAR) interacts with Neuropilin and
Tolloid-like protein (Neto)
1993). The AMPA and kainate receptors can be activated by
glutamate at the neuron resting potential of approximately
−70 mV. In contrast, at the resting potential, magnesium
(Mg2+) binds to the NMDA receptor to block the channel
pore preventing a response to glutamate. Upon membrane
depolarization by repetitive stimulation, Mg2+ is removed
from the NMDA receptor, enabling activation of the receptor. The activated NMDA receptor possesses high Ca2+ conductivity, which is implicated in synaptic plasticity. All
iGluR subunits have three transmembrane domains with 1
pore-loop, and a tetramer of these receptors forms a
glutamate- gated cationic channel. In the brain, several
iGluRs contain auxiliary subunits that stably bind to the
receptors and modulate receptor localization and/or channel
properties including pharmacology and activity.
30.2.2.1 AMPA Receptors (AMPARs)
AMPARs are composed of four subunits (GluA1–4), and all
AMPARs can form homotetramers. However, in hippocampal and other neurons, AMPARs form heteromeric Ca2+impermeable channels of GluA2 with GluA1/3/4 (Sommer
and Seeburg 1992). Importantly, GluA2 is subjected to RNA
editing and the resulting protein has an R (glutamine) instead
of a Q (arginine) in the pore-loop. This R/Q editing affects
the ion permeability as GluA2(R) is Ca2+ impermeable,
whereas GluA2(Q) is Ca2+ permeable. Several neurons,
including cerebellar stellate cells, express Ca2+-permeable

30 Glutamatergic Pathways andReceptors
https://t.me/medicina_free
199
AMPARs, indicating that GluA2 is absent in these AMPARs
(Liu and Cull-Candy 2000). Furthermore, to add to the complexity of this system, each subunit has splicing isoforms,
termed the ip/op isoforms, and the splicing site is located
on the extracellular domain and modulates receptor kinetics
(Sommer and Seeburg 1992).
In the brain, AMPARs contain auxiliary subunits (e.g.,
TARPs, GSG1L, CNIHs, and CKAMPs/Shisas) (Jackson and
Nicoll 2011; Jacobi and von Engelhardt 2021; Kamalova and
Nakagawa 2021; Schwenk etal. 2012; Yan and Tomita 2012).
TARPs have six isoforms (γ-2/3/4/5/7/8) that display distinct
expression patterns in the brain. CNIHs, GSG1L, and
CKAMPs/Shisa express broadly in the brain. Auxiliary subunits interact with AMPARs to modulate receptor properties,
pharmacology, and localization. For example, no synaptic
AMPAR activity is observed in the cerebellar granule cells
and in Purkinje cells with disruptive expression of TARPγ-2
and both γ-2/7, respectively (Hashimoto etal. 1999; Yamazaki
etal. 2010), indicating essential roles of TARPs in synaptic
AMPAR activity. Furthermore, AMPARs expressed in heterologous cells do not respond to kainic acid, whereas both
native AMPAR in the brain and AMPAR co-expressed with
TARPs respond to kainic acid (Tomita etal. 2005). To study
AMPAR in the brain, the incorporation of TARPs and other
auxiliary subunits into the receptors is required.
30.2.2.2 NMDA Receptors (NMDARs)
NMDAR is a heteromer of GluN1 and GluN2/3 that has high
Ca2+ permeability. Due to the blockage of the channel pore
by Mg+ at the resting potential, both glutamate binding and
Mg2+ removal by membrane depolarization are required for
NMDAR activation. Ca2+ inux through NMDAR plays
critical roles in synaptic plasticity. In long-term potentiation
(LTP), postsynaptic Ca2+ through NMDAR activates calmodulin (CaM) kinase II to increase synaptic AMPARs.
30.3 Glutamate Pathways inGlia Cells
In addition to neurons, glia cells also express glutamate
receptors, which are activated by glutamate released from
presynaptic terminals or ambient glutamate in the extracellular space to help glia function and development
(Volterra and Meldolesi 2005). In the cerebellum, the
Bergmann glia engulfs the parallel ber—Purkinje cell
synapses to form a tripartite synapse in the cerebellum
(Palay and Chan-Palay 1974). At this tripartite synapse,
Bergmann glia expresses AMPAR subunits, GluA1, and
GluA4. Elimination of both GluA1 and GluA2 from
Bergmann glia cells changes synaptic transmission at the
parallel ber-Purkinje cell synapses and synapse development (Saab et al. 2012), suggesting signicant roles of
glutamate receptors in glia.
30.4 Concluding Remarks
At excitatory synapses in the cerebellum, glutamate binds to
various types and classes of glutamate receptors. Each of
these receptors shows distinct expression, localization, and
properties, and combinatory receptor activity causes excitatory synaptic transmission. Furthermore, glutamate receptor disruption causes various neurological disorders. For
example, the disruption of NMDAR or both AMPAR and
KAR causes mouse lethality, whereas TARPγ-2 disruption
causes severe ataxia phenotypes. Furthermore, genome-wide
association study (GWAS) ndings have identied mutations in these receptor components in various neurological
disorders, including schizophrenia, epilepsy, and ataxia;
therefore, glutamate receptor complex components are considered to be drug targets for neurological disorders.
30.2.2.3 Kainate Receptors (KARs)
KARs have ve isoforms (GluK1–5). GluK1–3 form a
homo-tetramer; however, GluK4/5 cannot form a tetramer
and require GluK1–3 to function as a heterotetramer. Similar
to AMPARs, GluK1–3 can be subjected to Q/R editing to
alter Ca2+ permeability. Unlike AMPARs, KARs localize at
both pre- and post-synapses (Lerma 2006; Nicoll and
Schmitz 2005). At pre-synapses, KARs function as autoreceptors to modulate glutamate release, and at postsynapses, KARs function as membrane depolarizers, similar
to AMPARs. Furthermore, KARs and AMPARs play redundant roles at post-synapses (Yan et al. 2013). In addition,
KARs display distinctly slow kinetics, which are determined
by Neto1/2 auxiliary subunits (Copits and Swanson 2012;
Tomita and Castillo 2012). Neto1/2 interacts with KARs and
slows the decay kinetics of synaptic KARs without changes
in KAR localization.
References
Aiba A, Kano M, Chen C, Stanton ME, Fox GD, Herrup K, Zwingman
TA, Tonegawa S (1994) Decient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice. Cell
79:377–388
Bear MF, Huber KM, Warren ST (2004) The mGluR theory of fragile X
mental retardation. Trends Neurosci 27:370–377
Copits BA, Swanson GT (2012) Dancing partners at the synapse: auxil-
iary subunits that shape kainate receptor function. Nat Rev Neurosci
13:675–686
Dolen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S,
Bear MF (2007) Correction of fragile X syndrome in mice. Neuron
56:955–962
Hashimoto K, Fukaya M, Qiao X, Sakimura K, Watanabe M, Kano M
(1999) Impairment of AMPA receptor function in cerebellar granule
cells of ataxic mutant mouse stargazer. J Neurosci 19:6027–6036
Hollmann M, Heinemann S (1994) Cloned glutamate receptors. Annu
Rev Neurosci 17:31–108
Ito M (2006) Cerebellar circuitry as a neuronal machine. Prog Neurobiol
78:272–303

200
https://t.me/medicina_free
S. Tom it a
Jackson AC, Nicoll RA (2011) The expanding social network of iono-
tropic glutamate receptors: TARPs and other transmembrane auxil-
iary subunits. Neuron 70:178–199
Jacobi E, von Engelhardt J (2021) Modulation of information process-
ing by AMPA receptor auxiliary subunits. J Physiol 599:471–483
Jakab RL, Hamori J (1988) Quantitative morphology and synaptology
of cerebellar glomeruli in the rat. Anat Embryol (Berl) 179:81–88
Kamalova A, Nakagawa T (2021) AMPA receptor structure and auxil-
iary subunits. J Physiol 599:453–469
Lerma J (2006) Kainate receptor physiology. Curr Opin Pharmacol
6:89–97
Liu SQ, Cull-Candy SG (2000) Synaptic activity at calcium- permeable
AMPA receptors induces a switch in receptor subtype. Nature
405:454–458
Nakanishi S (1992) Molecular diversity of glutamate receptors and
implications for brain function. Science 258:597–603
Nicoll RA, Schmitz D (2005) Synaptic plasticity at hippocampal mossy
bre synapses. Nat Rev Neurosci 6:863–876
Niswender CM, Conn PJ (2010) Metabotropic glutamate receptors:
physiology, pharmacology, and disease. Annu Rev Pharmacol
Toxicol 50:295–322
Palay SL, Chan-Palay V (1974) Cerebellar cortex. Springer, NewYork
Saab AS, Neumeyer A, Jahn HM, Cupido A, Simek AA, Boele HJ,
Scheller A, Le Meur K, Gotz M, Monyer H etal (2012) Bergmann
glial AMPA receptors are required for ne motor coordination.
Science 337:749–753
Schwenk J, Harmel N, Brechet A, Zolles G, Berkefeld H, Muller CS,
Bildl W, Baehrens D, Huber B, Kulik A etal (2012) High-resolution
proteomics unravel architecture and molecular diversity of native
AMPA receptor complexes. Neuron 74:621–633
Sommer B, Seeburg PH (1992) Glutamate receptor channels: novel
properties and new clones. Trends Pharmacol Sci 13:291–296
Tomita S, Castillo PE (2012) Neto1 and Neto2: auxiliary subunits
that determine key properties of native kainate receptors. J Physiol
590:2217–2223
Tomita S, Adesnik H, Sekiguchi M, Zhang W, Wada K, Howe JR,
Nicoll RA, Bredt DS (2005) Stargazin modulates AMPA receptor
gating and trafcking by distinct domains. Nature 435:1052–1058
Volterra A, Meldolesi J (2005) Astrocytes, from brain glue to com-
munication elements: the revolution continues. Nat Rev Neurosci
6:626–640
Wisden W, Seeburg PH (1993) Mammalian ionotropic glutamate recep-
tors. Curr Opin Neurobiol 3:291–298
Yamazaki M, Fukaya M, Hashimoto K, Yamasaki M, Tsujita M, Itakura
M, Abe M, Natsume R, Takahashi M, Kano M etal (2010) TARPs
gamma-2 and gamma-7 are essential for AMPA receptor expression
in the cerebellum. Eur J Neurosci 31:2204–2220
Yan D, Tomita S (2012) Dened criteria for auxiliary subunits of gluta-
mate receptors. J Physiol 590:21–31
Yan D, Yamasaki M, Straub C, Watanabe M, Tomita S (2013)
Homeostatic control of synaptic transmission by distinct glutamate
receptors. Neuron 78:687–699

Norepinephrine intheCerebellum
https://t.me/medicina_free
HavenK.Predale, DanielJ.Chandler,
andBarryD.Waterhouse
31
Abstract
Although the presence of norepinephrine (NE) in the
mammalian cerebellum was initially controversial, there
is now substantial evidence of a role for the NE system in
modulating the response properties of individual cerebel-
lar neurons to synaptic inputs rather than transmitting
moment-to-moment details of modality-specic informa-
tion. As a result of these cellular actions, the noradrener-
gic system is capable of regulating cerebellar circuit
functions within the context of ongoing voluntary and
reex motor activities and in a manner appropriate to the
behavioral state of the organism. The evidence for this
mode of operation derives from extensive anatomical,
physiological, and pharmacological investigations over a
period of more than 50years. This chapter summarizes
those studies and the development of this concept.
Implications for developmental disorders and pathologi-
cal conditions involving the cerebellum are also
discussed.
Keywords
Norepinephrine · Locus coeruleus · Noradrenergic
Neurotransmitter · Neuromodulation · Cerebellum
Purkinje cells · Coeruleo-cerebellar pathway
31.1 Anatomical Considerations
Early uorescent histochemical (Andén etal. 1967) and biochemical (Iversen and Glowinski 1966) studies provided the
rst evidence of norepinephrine (NE)-containing bers
within the cerebellar cortex. Later anatomical, physiological,
H. K. Predale · D. J. Chandler · B. D. Waterhouse (*)
Department of Cell Biology and Neuroscience, Rowan University
School of Osteopathic Medicine, Stratford, NJ, USA
e-mail: predal25@rowan.edu; chandlerd@rowan.edu;
waterhouse@rowan.edu
and pharmacological experiments (Bloom etal. 1971; Hoffer
etal. 1971, 1973; Siggins etal. 1971a, b) conrmed the exis-
tence of a prominent NE pathway from the brainstem nucleus
locus coeruleus (LC) to all regions of the cerebellar cortex
and deep cerebellar nuclei (Olson and Fuxe 1971). The LC is
a small, bilateral nucleus located in the brainstem, ventral to
the cerebellum and lateral to the fourth ventricle that contains approximately 45,000–50,000 neurons in the adult
human and about 3000 neurons in rodent (Poe etal. 2020;
Swanson 1976; Von Coelln et al. 2004; Liu et al. 2013).
Within the cerebellar cortex, NE bers arising from LC terminate primarily in the inner portion of the molecular, granule, and Purkinje cell layers, with no contact made in the
cerebellar white matter (Bloom etal. 1971). The deep cerebellar nuclei also receive noradrenergic input from LC, presumably from collaterals of axons ascending to the cortex
(Carlson etal. 2021). The LC-cerebellar pathway arises from
NE-containing cell bodies that are distributed throughout the
rostral-caudal extent of the ipsilateral and contralateral
nucleus (see Fig.31.1). In early studies, electrical stimulation of the LC resulted in the suppression of Purkinje cell
spontaneous discharge, further supporting the existence of
an input pathway from LC to the cerebellum (Siggins etal.
1971a). Aside from LC afferents, there is evidence that a
subset of Purkinje neurons is capable of synthesizing catecholamine transmitter (Locke etal. 2020).
Because of the small number of LC neurons in the brainstem, and the broad expanse of cerebellar tissue, it must be
assumed that individual LC cells give rise to axons that collateralize extensively throughout the cerebellum. Currently,
we know little about the branching patterns and distribution
of LC-NE axon collaterals within the cerebellum or elsewhere in the brain. Such information would provide new
insight regarding the topographic specicity of interactions
between LC output and cerebellar operations.
Immunohistochemical studies using antibodies against
tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis, further conrmed the existence of cat-
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023
D. L. Gruol et al. (eds.), Essentials of Cerebellum and Cerebellar Disorders, https://doi.org/10.1007/978-3-031-15070-8_31
201

202
https://t.me/medicina_free
H. K. Predale et al.
Fig. 31.1 Enhanced green uorescent protein (EGFP)+NE-containing
cells in the ipsi- (at right) and contralateral (at left) LC nucleus following retrograde delivery of the canine adenovirus encoding Cre recombinase (CAV2-CMV-Cre) from the medial nucleus of the mouse
cerebellum. Mice were heterozygous for En1
Dre
, Dbh
Flpo
, and the
echolamine afferents to the cerebellum in both rat (Kimoto
etal. 1978) and mouse (Landis et al. 1975). Although TH
labeling can also be a biomarker for dopamine cell bodies
and bers, studies using antibodies against dopamine have
revealed only a limited distribution of dopaminergic bers in
the cerebellum (Nelson et al. 1997) indicating that NE
remains the dominant catecholamine transmitter in the cerebellum. Recent work by Flace etal. indicates that dopaminergic innervation of the lobules in the cerebellar cortex and
deep cerebellar nuclei varies among different species (Flace
etal. 2021).
Traditionally, the cerebellum has been viewed as a motor
control center; engaged in planning movement, providing for
on-line correction of movements in progress, and exerting a
major inuence on balance, posture, and eye movements. It
achieves its role in motor control through massive connections with the primary motor cortex, brainstem, and spinal
cord. However, substantial evidence indicates that a large
portion of the cerebellar circuitry is dedicated to non-motor
functions (Stoodley and Schmahmann 2010; Strick et al.
2009; Schmahmann 2019; Schmahmann etal. 2019). Studies
on strokes in humans showed that motor decits resulted
from stroke-induced damage in the anterior lobe of the cerebellum, but not from insult to the posterior or occulonodular lobes (Schmahmann et al. 2009). Additional stroke
studies noted that the posterior lobe of the cerebellum
appears to be necessary for learned fear (Sacchetti et al.
2009). Finally, recent studies in mice (Carlson etal. 2021;
Locke et al. 2018, 2020) have shown that catecholaminecontaining Purkinje cells and catecholamine regulated output from the lateral nucleus of cerebellum can modulate
cognitive behaviors. Taken together, these reports conrm
RC::RFLTG indicator allele (Jensen Laboratory, NIEHS). LC-NE neurons are labeled constitutively with tdTomato (red uorescence) and
switch to EGFP (green uorescence) after Cre recombination (Plummer
etal. 2020, eNeuro)
the existence of non-motor regions of the cerebellum and
catecholaminergic inuence over non-motor cerebellar functions. Nevertheless, the specic role of the LC-NE system in
regulating non-motor operations of the cerebellum has yet to
be fully detailed.
31.2 Physiology ofNE
inCerebellum—Cellular Actions
NE was initially viewed as an inhibitory transmitter in the
cerebellum. However, later studies demonstrated differential
effects of NE on spontaneous and evoked discharge of
Purkinje neurons that are best described as neuromodulatory
(Freedman etal. 1977; Moises etal. 1979, 1990). NE suppresses Purkinje cell spontaneous discharge but reduces
mossy ber- or climbing ber evoked excitation to a lesser
extent or not all, yielding a net increase in signal to noise
ratio, i.e., the ratio of the change in stimulus evoked versus
spontaneous discharge. In addition, NE augments inhibitory
responses of Purkinje neurons to afferent pathway stimulation (Freedman etal. 1976, 1977). Thus, NE is capable of
producing a relative or absolute enhancement of stimulusdriven activity in the primary output cells of the cerebellar
cortex. Beyond these actions, a “gating” effect has been
observed whereby Purkinje cells exhibiting little or no
response to peripheral stimuli become responsive to such
inputs in the presence of NE (cf. Fig.5—Moises etal. 1990).
Collectively, the evidence indicates that NE can produce a
spectrum of effects on spontaneous and evoked discharge of
Purkinje neurons, all of which serve to regulate the responsiveness of these cells to synaptically driven inputs. It is

31 Norepinephrine intheCerebellum
https://t.me/medicina_free
203
important to note that despite anatomical evidence of noradrenergic innervation of the deep cerebellar nuclei (Olson and
Fuxe 1971), the effect of NE release on response properties
of cells in the deep cerebellar nuclei has not been
elucidated.
Further tests showed that NE’s neuromodulatory action
on inhibitory transmission to Purkinje cells was specic for
GABA. For example, Moises et al. (1979) showed that
glycine- induced inhibition of Purkinje cell ring was not
enhanced by NE application, and Yeh etal. (1981) showed
that NE did not enhance Purkinje cell inhibition elicited by
direct application of taurine or beta-alanine, inhibitory amino
acids that are structurally similar to GABA. Despite these
demonstrations of specicity for GABA, NE can also
enhance Purkinje neuron responses to the excitatory amino
acid transmitter glutamate (Moises etal. 1979). Importantly,
the facilitating effects of NE on amino acid evoked responses
in Purkinje neurons have been demonstrated in waking animals (West and Woodward 1984) suggesting these actions
are indeed physiologically relevant.
Activation of the noradrenergic input pathway from the
LC results in modulatory actions similar to those observed
following local application of NE to Purkinje neurons. For
example, phasic patterns of LC electrical stimulation that
mimic physiologic discharge along the coeruleo-cerebellar
pathway result in prominent modulation of Purkinje neuron
responses to excitatory and inhibitory synaptic inputs; both
climbing ber and parallel ber excitation as well as inhibition mediated by local inhibitory interneurons [cf. Fig.5—
Moises et al. (1981), cf. Fig. 2—Moises et al. (1983)]. In
addition, LC stimulation increases the probability of Purkinje
cell discharge in response to otherwise sub-threshold activation of the climbing ber input pathway [cf. Fig.5—Moises
et al. (1981)]. As in other brain regions (Berridge and
Waterhouse 2003; Waterhouse and Navarra 2019), these
LC-NE modulatory effects follow an inverted-U function
(Moises etal. 1981) suggesting that state-dependent uctuations in LC output can adjust cerebellar circuit operations
across a dynamic range, one that is capable of optimizing or
minimizing function as behavioral contingencies change.
31.3 Noradrenergic Receptors
inCerebellum
The net effect of NE on cerebellar network properties not
only depends on the cellular type on which it acts, but also
the receptor expression and localization, and concurrent
excitatory or inhibitory afferent drive impinging on the neuron. Three main subtypes of adrenergic receptors exist: α1, β,
and α2, each of which is coupled to a distinct intracellular
signaling pathway that produces unique effects on cellular
physiology. While NE was originally characterized as an
inhibitory transmitter in cerebellum, it is now quite apparent
that it functions as a neuromodulator, altering the response
properties of target neurons by facilitating the actions of
other transmitters. The net impact of the LC-NE system on
cerebellar circuit function derives from the constellation of
actions mediated by individual receptor sub-types.
Βeta Receptor Activation Suppresses Purkinje Cell Discharge and Augments GABA-Mediated Inhibitory
Action It has been very clearly demonstrated that NE
reduces the spontaneous ring rate of cerebellar Purkinje
neurons (Bickford-Wimer etal. 1991), and potentiates the
inhibitory response of these neurons to GABAergic neurotransmission (Cheun and Yeh 1992, 1996; Llano and Gerschenfeld 1993). Furthermore, the decline in the spontaneous
ring rate of Purkinje neurons is very tightly correlated with
NE efux (Bickford-Wimer et al. 1991). These inhibitory
responses are mediated by β-receptor activation (Cheun and
Yeh 1992, 1996; Llano and Gerschenfeld 1993; Saitow and
Konishi 2000; Saitow etal. 2000). Microiontophoretic application of the β agonist isoproterenol mimics the effect of NE
administration on the ring rate of Purkinje neurons and
GABA-mediated inhibition, while α-adrenergic drugs have
no effect (Cheun and Yeh 1992; Llano and Gerschenfeld
1993; Lin etal. 1991).
The transmembrane β receptor is Gs protein coupled and
activates protein kinase A (PKA)-dependent intracellular
signaling cascades to phosphorylate various proteins, ultimately increasing the sensitivity of the neuron to afferent
inhibitory inputs. A proposed molecular mechanism by
which this occurs is phosphorylation of an intracellular
domain of the GABA receptor itself, which produces a conformational change that increases GABA-dependent chloride currents to hyperpolarize the neuron (Cheun and Yeh
1992; Sweetnam etal. 1988; Kirkness etal. 1989). As such,
the discharge properties of Purkinje cells are sensitive to
manipulations that target the downstream signaling cascade
of β activation: for example, forskolin, a potent activator of
adenylate cyclase, increases the frequency of inhibitory postsynaptic currents (IPSC) in cerebellar Purkinje and stellate
cells (Llano and Gerschenfeld 1993; Kondo and Marty
1997), while 8-bromo-cAMP, a membrane permeant analog
of cAMP resistant to degradation by cAMP phosphodiesterase, mimics the effect of NE application on GABAergic inhibition of Purkinje neurons (Cheun and Yeh 1992).
The Αlpha 1 Receptor Suppresses Purkinje Cell
Discharge Via a Presynaptic Mechanism In the cerebel-
lum, the cellular localization of α1 adrenergic receptors
remains somewhat inconclusive. α1 Receptors have been
reported primarily on Bergmann glial cells (Herold et al.
2005). Due to the regulatory role that glia play in neuronal
transmitter release and uptake, metabolism, morphology, and

204
https://t.me/medicina_free
H. K. Predale et al.
connectivity, activation of glial α1 receptors may account for
some of the changes in neuronal discharge properties that are
associated with α1 receptor stimulation (Kulik etal. 1999;
Hirono and Obata 2006). However, there is also evidence
that α1 receptors are located presynaptically on interneurons,
and their activation causes release of intracellular calcium to
increase the frequency of inhibitory postsynaptic currents in
Purkinje cells, leading to neuronal inhibition (Hirono and
Obata 2006). Importantly, this effect can be suppressed by
blocking phospholipase C, but not PKA, suggesting that it is
an effect independent of β receptor signaling. Despite the
apparent widespread distribution of this receptor on both
neuronal and non-neuronal cells, its activation consistently
increases the frequency and amplitude of both spontaneous
and evoked inhibitory postsynaptic potentials, likely due to
an increase of presynaptic GABA release (Kulik etal. 1999;
Hirono and Obata 2006). Therefore, both α1 and β receptors
inhibit tonic Purkinje discharge. Although these effects are
likely mediated by distinct cellular and molecular mechanisms, they act synergistically to modulate the signal-tonoise ratio of Purkinje neurons.
Activation of the α2 Receptor Suppresses Inhibition of
Purkinje Cells Presynaptically α2 Receptors are located
presynaptically on interneurons within the cerebellar cortex
(Hirono and Obata 2006). Like the other adrenergic receptors, the α2 receptor spans the membrane and is coupled to an
intracellular G protein signaling cascade. However, unlike
the other adrenergic receptors, its activation stimulates Gi
proteins, which leads to opposing intracellular actions of β
receptor activation and reducing intracellular cAMP concentration, inhibiting voltage-gated calcium channels, and activating inward rectifying potassium channels. Furthermore,
activation of this adrenergic receptor subtype decreases the
amplitude of hyperpolarization-activated nonselective cation
currents, which inhibits the release of both glutamate and
GABA from terminals by decreasing the ring rate of presynaptic interneurons (Hirono and Obata 2006; Hirono etal.
2008). This is achieved by suppressing spike generation at
both dendrites and somata (Hirono and Obata 2006), thereby
decreasing the ability of neurons to propagate action potentials and release transmitter onto postsynaptic Purkinje neurons. Therefore, the ultimate effect of presynaptic α2 receptor
activation is a net disinhibition of Purkinje cell discharge.
This receptor appears to be necessary to ne-tune motor
coordination. Interestingly, genetically altered mice who do
not express a subtype of the α2 receptor display impaired
motor coordination (Lahdesmaki etal. 2002), which may be
due in part to the lack of the receptor within cerebellum.
While it is valuable to identify individual receptor mechanisms responsible for NE actions, one must consider the
combined effect of LC activation and NE release in the context of global cerebellar function and whole animal behavior.
In this context, it is important to remember that under physiologic conditions, noradrenergic receptors do not operate
independently, but rather are all subject to simultaneous activation by NE release according to their afnity for NE;
α2a>α1>β. It is important to note that to date there is no
evidence of differential expression of adrenergic receptors
across the cerebellum. Based upon the distribution of DBHpositive bers, the assumption is that adrenergic receptors
are present in both the cortex and deep cerebellar nuclei.
Studies to date suggest the β, α1, and α2 adrenergic receptors
act both pre- and postsynaptically to synergistically modulate cerebellar network properties and subsequent motor
behaviors. One additional caveat is that variances in receptor
sensitivity and expression could most certainly dictate the
net outcome of NE release on cerebellar operations.
31.4 Functional Implications
Impact of the LC-NE System on Motor and Non-motor
Functions of the Cerebellum The cerebellum through its
afferent and efferent connections serves both motor and nonmotor functions (Strick etal. 2009; Schmahmann 2019). The
role of NE in regulating these functions is clear in some
cases but speculative in many others. Several reexes mediated by the cerebellum are modulated by NE, indicating that
the effects of NE on individual neuron and neural network
properties impact signicantly the motor-related output of
the cerebellum. For example, the vestibular ocular reex
(VOR) relies on output from the occulus of the cerebellum
to stabilize images on the retina during a head movement by
proportionately rotating the eyes in the direction opposite to
that of head movement. It has been shown experimentally
that β receptor agonists and antagonists are capable of
increasing and decreasing, respectively, the ability of this
reex to keep a visual stimulus stabilized on the retina (van
Neerven etal. 1990).
Anatomical studies have clearly demonstrated input–output connections between the cerebellum and cognitive centers of the brain (Strick et al. 2009; Schmahmann 2019).
Recently, Carlson etal. demonstrated LC projections and
LC-mediated release of catecholamines, presumably NE, in
the lateral nucleus of the mouse cerebellum (Carlson etal.
2021). Following selective depletion of catecholamine bers
in the lateral nucleus, these authors observed decits in tasks
that measure sensorimotor integration, associative fear learning, response inhibition, and working memory; but not in
tasks assessing motor coordination, vestibular function, or
gait. These ndings conrm a role for the LC-NE system in
non-motor cerebellar-mediated functions.
The above ndings suggest a role for NE in moment-tomoment regulation of cerebellar operations. Thus, as LC output waxes and wanes across the waking cycle, NE release in
Соседние файлы в папке Библиотека им академика М.И. Перельмана
